AAPL322.01-6.20 (-1.89%) ▼|ABBV256.00-4.22 (-1.62%) ▼|ABT109.00+0.21 (+0.19%) ▲|ACN187.09-6.04 (-3.13%) ▼|ADBE268.59-17.16 (-6.01%) ▼|AMAT452.21+16.30 (+3.74%) ▲|AMD471.72+15.56 (+3.41%) ▲|AMGN436.90-7.22 (-1.63%) ▼|AMT175.81-1.94 (-1.09%) ▼|AMZN258.26-0.65 (-0.25%) ▼|AVGO356.28-0.88 (-0.25%) ▼|AXP326.71-3.11 (-0.94%) ▼|BA211.69+1.18 (+0.56%) ▲|BAC62.64-0.08 (-0.13%) ▼|BKNG193.63-1.50 (-0.77%) ▼|BLK1,121.80-4.35 (-0.39%) ▼|BMY66.65-1.44 (-2.11%) ▼|BNY165.23+0.90 (+0.55%) ▲|BRK-B505.99-2.14 (-0.42%) ▼|C137.72-0.42 (-0.30%) ▼|CAT810.20+10.06 (+1.26%) ▲|CL89.04-1.05 (-1.17%) ▼|CMCSA26.51-0.14 (-0.53%) ▼|COF219.19-1.31 (-0.59%) ▼|COP134.48-1.24 (-0.91%) ▼|COST917.72-7.70 (-0.83%) ▼|CRM260.49-3.94 (-1.49%) ▼|CSCO109.30+0.69 (+0.64%) ▲|CVS96.97-0.23 (-0.24%) ▼|CVX208.44-2.88 (-1.36%) ▼|DE695.87+1.46 (+0.21%) ▲|DHR207.45-3.58 (-1.70%) ▼|DIS105.76-1.40 (-1.31%) ▼|DUK120.26-1.14 (-0.94%) ▼|EMR152.49+2.28 (+1.51%) ▲|FDX321.96-2.36 (-0.73%) ▼|GD358.54-7.33 (-2.00%) ▼|GE336.44+2.96 (+0.89%) ▲|GEV941.39-0.46 (-0.05%) ▼|GILD150.41-0.81 (-0.54%) ▼|GM87.45+0.41 (+0.47%) ▲|GOOG336.11-2.97 (-0.87%) ▼|GOOGL339.36-2.90 (-0.85%) ▼|GS1,036.76-1.18 (-0.11%) ▼|HD321.52+3.45 (+1.08%) ▲|HON208.64+1.01 (+0.48%) ▲|IBM234.35-0.36 (-0.15%) ▼|INTC94.71+3.04 (+3.32%) ▲|INTU332.41-11.89 (-3.45%) ▼|ISRG366.92-2.92 (-0.79%) ▼|JNJ275.37-3.07 (-1.10%) ▼|JPM358.04-4.02 (-1.11%) ▼|KO88.04-0.77 (-0.87%) ▼|LIN478.46-3.74 (-0.77%) ▼|LLY1,142.99-16.61 (-1.43%) ▼|LMT524.92-8.03 (-1.51%) ▼|LOW205.05+3.15 (+1.56%) ▲|LRCX303.28+10.62 (+3.63%) ▲|MA581.09-4.62 (-0.79%) ▼|MCD256.62-3.01 (-1.16%) ▼|MDLZ61.48+0.03 (+0.04%) ▲|MDT94.32+1.22 (+1.31%) ▲|META615.44+4.76 (+0.78%) ▲|MMM168.37+0.06 (+0.03%) ▲|MO69.00-0.50 (-0.71%) ▼|MRK150.28-2.06 (-1.35%) ▼|MS217.02-0.13 (-0.06%) ▼|MSFT500.11-10.01 (-1.96%) ▼|MU1,003.46+45.30 (+4.73%) ▲|NEE83.42-0.64 (-0.76%) ▼|NFLX78.76-3.92 (-4.74%) ▼|NKE38.57-0.21 (-0.53%) ▼|NOW141.24-4.35 (-2.99%) ▼|NVDA229.89+1.44 (+0.63%) ▲|ORCL156.89+2.85 (+1.85%) ▲|PEP137.85-0.70 (-0.50%) ▼|PFE28.42-0.39 (-1.35%) ▼|PG146.32-0.61 (-0.41%) ▼|PLTR174.25-8.28 (-4.54%) ▼|PM182.65-3.52 (-1.89%) ▼|QCOM167.28-1.29 (-0.77%) ▼|RTX200.65-1.48 (-0.73%) ▼|SBUX104.87-0.95 (-0.90%) ▼|SCHW109.47-0.91 (-0.82%) ▼|SO87.96-0.82 (-0.92%) ▼|SPG210.17-1.35 (-0.64%) ▼|T25.78-0.42 (-1.58%) ▼|TMO612.37-6.06 (-0.98%) ▼|TMUS182.89-5.13 (-2.73%) ▼|TSLA354.76-21.61 (-5.74%) ▼|TXN257.59+3.76 (+1.48%) ▲|UBER76.41+0.45 (+0.59%) ▲|UNH395.68-5.26 (-1.31%) ▼|UNP289.99+0.84 (+0.29%) ▲|UPS102.41-1.10 (-1.06%) ▼|USB63.37-0.17 (-0.26%) ▼|V374.63-4.12 (-1.09%) ▼|VZ50.27-0.33 (-0.64%) ▼|WFC89.82+0.63 (+0.71%) ▲|WMT107.32-1.10 (-1.01%) ▼|XOM159.78-2.44 (-1.50%) ▼|AAPL322.01-6.20 (-1.89%) ▼|ABBV256.00-4.22 (-1.62%) ▼|ABT109.00+0.21 (+0.19%) ▲|ACN187.09-6.04 (-3.13%) ▼|ADBE268.59-17.16 (-6.01%) ▼|AMAT452.21+16.30 (+3.74%) ▲|AMD471.72+15.56 (+3.41%) ▲|AMGN436.90-7.22 (-1.63%) ▼|AMT175.81-1.94 (-1.09%) ▼|AMZN258.26-0.65 (-0.25%) ▼|AVGO356.28-0.88 (-0.25%) ▼|AXP326.71-3.11 (-0.94%) ▼|BA211.69+1.18 (+0.56%) ▲|BAC62.64-0.08 (-0.13%) ▼|BKNG193.63-1.50 (-0.77%) ▼|BLK1,121.80-4.35 (-0.39%) ▼|BMY66.65-1.44 (-2.11%) ▼|BNY165.23+0.90 (+0.55%) ▲|BRK-B505.99-2.14 (-0.42%) ▼|C137.72-0.42 (-0.30%) ▼|CAT810.20+10.06 (+1.26%) ▲|CL89.04-1.05 (-1.17%) ▼|CMCSA26.51-0.14 (-0.53%) ▼|COF219.19-1.31 (-0.59%) ▼|COP134.48-1.24 (-0.91%) ▼|COST917.72-7.70 (-0.83%) ▼|CRM260.49-3.94 (-1.49%) ▼|CSCO109.30+0.69 (+0.64%) ▲|CVS96.97-0.23 (-0.24%) ▼|CVX208.44-2.88 (-1.36%) ▼|DE695.87+1.46 (+0.21%) ▲|DHR207.45-3.58 (-1.70%) ▼|DIS105.76-1.40 (-1.31%) ▼|DUK120.26-1.14 (-0.94%) ▼|EMR152.49+2.28 (+1.51%) ▲|FDX321.96-2.36 (-0.73%) ▼|GD358.54-7.33 (-2.00%) ▼|GE336.44+2.96 (+0.89%) ▲|GEV941.39-0.46 (-0.05%) ▼|GILD150.41-0.81 (-0.54%) ▼|GM87.45+0.41 (+0.47%) ▲|GOOG336.11-2.97 (-0.87%) ▼|GOOGL339.36-2.90 (-0.85%) ▼|GS1,036.76-1.18 (-0.11%) ▼|HD321.52+3.45 (+1.08%) ▲|HON208.64+1.01 (+0.48%) ▲|IBM234.35-0.36 (-0.15%) ▼|INTC94.71+3.04 (+3.32%) ▲|INTU332.41-11.89 (-3.45%) ▼|ISRG366.92-2.92 (-0.79%) ▼|JNJ275.37-3.07 (-1.10%) ▼|JPM358.04-4.02 (-1.11%) ▼|KO88.04-0.77 (-0.87%) ▼|LIN478.46-3.74 (-0.77%) ▼|LLY1,142.99-16.61 (-1.43%) ▼|LMT524.92-8.03 (-1.51%) ▼|LOW205.05+3.15 (+1.56%) ▲|LRCX303.28+10.62 (+3.63%) ▲|MA581.09-4.62 (-0.79%) ▼|MCD256.62-3.01 (-1.16%) ▼|MDLZ61.48+0.03 (+0.04%) ▲|MDT94.32+1.22 (+1.31%) ▲|META615.44+4.76 (+0.78%) ▲|MMM168.37+0.06 (+0.03%) ▲|MO69.00-0.50 (-0.71%) ▼|MRK150.28-2.06 (-1.35%) ▼|MS217.02-0.13 (-0.06%) ▼|MSFT500.11-10.01 (-1.96%) ▼|MU1,003.46+45.30 (+4.73%) ▲|NEE83.42-0.64 (-0.76%) ▼|NFLX78.76-3.92 (-4.74%) ▼|NKE38.57-0.21 (-0.53%) ▼|NOW141.24-4.35 (-2.99%) ▼|NVDA229.89+1.44 (+0.63%) ▲|ORCL156.89+2.85 (+1.85%) ▲|PEP137.85-0.70 (-0.50%) ▼|PFE28.42-0.39 (-1.35%) ▼|PG146.32-0.61 (-0.41%) ▼|PLTR174.25-8.28 (-4.54%) ▼|PM182.65-3.52 (-1.89%) ▼|QCOM167.28-1.29 (-0.77%) ▼|RTX200.65-1.48 (-0.73%) ▼|SBUX104.87-0.95 (-0.90%) ▼|SCHW109.47-0.91 (-0.82%) ▼|SO87.96-0.82 (-0.92%) ▼|SPG210.17-1.35 (-0.64%) ▼|T25.78-0.42 (-1.58%) ▼|TMO612.37-6.06 (-0.98%) ▼|TMUS182.89-5.13 (-2.73%) ▼|TSLA354.76-21.61 (-5.74%) ▼|TXN257.59+3.76 (+1.48%) ▲|UBER76.41+0.45 (+0.59%) ▲|UNH395.68-5.26 (-1.31%) ▼|UNP289.99+0.84 (+0.29%) ▲|UPS102.41-1.10 (-1.06%) ▼|USB63.37-0.17 (-0.26%) ▼|V374.63-4.12 (-1.09%) ▼|VZ50.27-0.33 (-0.64%) ▼|WFC89.82+0.63 (+0.71%) ▲|WMT107.32-1.10 (-1.01%) ▼|XOM159.78-2.44 (-1.50%) ▼|
29.8 C
New York
Friday, September 4, 2026

Tag: patients

newssourceFORcompanyinformationcontent1releasesmarket

Vanda Pharmaceuticals to Announce Second Quarter 2025 Financial Results on July 31, 2025

Conference Call and Webcast to Follow WASHINGTON, July 23, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for...

Abivax Announces Launch of Public Offering

Abivax Announces Launch of Public Offering

Galapagos Bolster Leadership Team with Seasoned Life Sciences Executives to Accelerate Business Transformation

Appoints Sooin Kwon as Chief Business Officer and Dan Grossman as Chief Strategy Officer

iMedX Endorsed by Health New Zealand as Approved Ambient AI Scribe Tool

Partnership with DeliverHealth brings InstaNote (eSOne platform) to New Zealand clinicians AUCKLAND, New Zealand, July 23, 2025 /PRNewswire/ -- iMedX is proud to announce its formal endorsement by Health New Zealand | Te...

British Columbia Joins Other Provincial Public Drug Plans Now Reimbursing FOQUEST® on their Formulary for Attention Deficit Hyperactivity Disorder (ADHD)

TORONTO, July 23, 2025 /CNW/ - Elvium Life Sciences is pleased to announce the addition of FOQUEST® (methylphenidate hydrochloride controlled release capsules) to the British...

NAPA Anesthesia Honored with RPI Best Practice Standards® Award for Excellence in Employee Recognition

SUNRISE, Fla., July 23, 2025 /PRNewswire/ -- North American Partners in Anesthesia (NAPA), the nation's largest single-specialty anesthesia services organization, has been awarded a...

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alto Neuroscience

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Alto To Contact Him Directly To...

Key Opinion Leader Event Highlights Pelareorep’s Compelling Pancreatic and Gastrointestinal Data And Future Potential

SAN DIEGO and CALGARY, AB, July 23, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for...

Key Opinion Leader Event Highlights Pelareorep’s Compelling Pancreatic and Gastrointestinal Data And Future Potential

SAN DIEGO and CALGARY, AB, July 23, 2025 /CNW/ -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for...

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Aidoc Secures $150M for CARE, its Healthcare Foundation Model, to Transform Clinical Decision-Making for 100 Million Patients

The Era of Clinical AI Has Arrived: Trusted by Leading Health Systems, Aidoc's Platform Brings AI to the Heart of Patient Care NEW YORK, July 23,...

Indivior Real World Evidence Study Finds Medications for Opioid Use Disorder, Particularly Extended-Release Buprenorphine, Reduced Odds of Emergency Department Visits for Patients with Opioid...

Extended-release buprenorphine (BUP-XR) had lower rates of hospitalizations, emergency department (ED) visits, and outpatient physician office visits compared to those receiving daily oral buprenorphine or no medications for...

Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada

- XIPERE Now Approved for Use in Multiple Global Markets -

The Power of Massage Therapy for Autoimmune Diseases: AMTA Highlights Emerging Research

EVANSTON, Ill., July 23, 2025 /PRNewswire/ -- The American Massage Therapy Association (AMTA) is committed to advancing integrative health care by spotlighting the powerful role...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPatients

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers